Zobrazeno 1 - 10
of 2 413
pro vyhledávání: '"Burden of illness"'
Homologous Recombination Repair Testing Patterns and Outcomes in mCRPC by Alteration Status and Race
Autor:
Bilen MA, Khilfeh I, Rossi C, Muser E, Morrison L, Hilts A, Diaz L, Lefebvre P, Pilon D, George DJ
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 16, Pp 657-674 (2024)
Mehmet Asim Bilen,1 Ibrahim Khilfeh,2 Carmine Rossi,3 Erik Muser,2 Laura Morrison,3 Annalise Hilts,3 Lilian Diaz,3 Patrick Lefebvre,3 Dominic Pilon,3 Daniel J George4 1Department of Hematology and Medical Oncology, Emory University School of Medicine
Externí odkaz:
https://doaj.org/article/21b1cbb5bb98427383e18c20de7c5a9f
Publikováno v:
Zhongguo quanke yixue, Vol 27, Iss 27, Pp 3388-3394 (2024)
Background The disease burden of ischemic heart disease is becoming heavier, and the influence of metabolic factors is gradually increasing, and there is still insufficient research in exploring the disease burden caused by metabolic factors and its
Externí odkaz:
https://doaj.org/article/2c6c412a78654829bf2cf1ae0d6f4a52
Publikováno v:
Journal of Blood Medicine, Vol Volume 15, Pp 363-386 (2024)
Ping Du,1 Tiffany Cristarella,2 Camille Goyer,2 Yola Moride2,3 1Global Evidence and Outcomes, Takeda Development Center Americas, Inc., Cambridge, MA, USA; 2YolaRX Consultants Inc., Montreal, QC, Canada; 3Center for Pharmacoepidemiology and Treatment
Externí odkaz:
https://doaj.org/article/2d4aa41f011541779e8ece84cd3a6c25
Publikováno v:
International Journal of COPD, Vol Volume 19, Pp 1033-1046 (2024)
Melissa H Roberts,1 David M Mannino,2,3 Douglas W Mapel,4 Orsolya Lunacsek,5 Shahla Amin,5 Eileen Farrelly,5 Norbert Feigler,6 Michael F Pollack6 1College of Pharmacy, University of New Mexico, Albuquerque, NM, USA; 2College of Medicine, University o
Externí odkaz:
https://doaj.org/article/58761d24f0d84985b9fbc8e2416817e4
Publikováno v:
Zhongguo quanke yixue, Vol 27, Iss 13, Pp 1601-1607 (2024)
Background Chronic diseases have become a major public health problem affecting the health of the population, and the number of patients with chronic diseases in China continues to increase, as well as the increasing number of deaths due to chronic d
Externí odkaz:
https://doaj.org/article/fad451a0993f4cbfb931e2069e03745b
Autor:
HE Jiahui, HU Qinyong
Publikováno v:
Zhongliu Fangzhi Yanjiu, Vol 51, Iss 4, Pp 271-277 (2024)
Objective To analyze trends in the disease burden of esophageal cancer attributable to high body mass index (BMI) in the Chinese and United States populations from 1990 to 2019 and predict deaths over the next 10 years. Methods This study used Global
Externí odkaz:
https://doaj.org/article/1a92e370ca834a109023b02805dfe9f3
Autor:
Abigail Ortiz, Milos Milic, Marcos Sanches, M. Ishrat Husain, Benoit H. Mulsant, Daniel Felsky
Publikováno v:
Psychiatry Research Communications, Vol 4, Iss 3, Pp 100192- (2024)
Introduction: Patients with bipolar disorder (BD) face disproportionate rates of cardiovascular disease. While several mechanisms have been proposed for this association, both are multifactorial and heterogeneous illnesses, and it is unlikely that an
Externí odkaz:
https://doaj.org/article/1adea2b5494e4c64b0369822c23fda55
Publikováno v:
Zhongguo quanke yixue, Vol 27, Iss 09, Pp 1126-1133 (2024)
Background China ranks first in the world in terms of the number of diabetes patients. In recent years, the prevalence and mortality of diabetes have been rising, threatening people's health and placing a heavy burden on the people of China. As the p
Externí odkaz:
https://doaj.org/article/21902834e42b4202b1e8aacfa6899143
Publikováno v:
European Journal of Medical Research, Vol 29, Iss 1, Pp 1-26 (2024)
Abstract Background Metachromatic leukodystrophy (MLD; OMIM 250100 and 249900) is a rare lysosomal storage disease caused by deficient arylsulfatase A activity, leading to accumulation of sulfatides in the nervous system. This systematic literature r
Externí odkaz:
https://doaj.org/article/b0f4ee0747944b2ca1bbe6ae9c821918
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 16, Pp 123-132 (2024)
Dilek Gogas Yavuz,1 Omar Akhtar,2 Kaywei Low,2 Adrien Gras,2 Batu Gurser,3 Esra Safak Yilmaz,4 Amaury Basse5 1School of Medicine, Marmara University, Section of Endocrinology and Metabolism, Istanbul, Turkey; 2Healthcare Market Access, Ipsos, Singapo
Externí odkaz:
https://doaj.org/article/d6104eb643c34f48ab3157fc447cc426